相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Physicochemical Stability of Monoclonal Antibodies: A Review
Yoann Le Basle et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Directed evolution methods for overcoming trade-offs between protein activity and stability
Samuel D. Stimple et al.
AICHE JOURNAL (2020)
Heparin chromatography as an in vitro predictor for antibody clearance rate through pinocytosis
Thomas E. Kraft et al.
MABS (2020)
T cell epitope mapping of secukinumab and ixekizumab in healthy donors
Sebastian Spindeldreher et al.
MABS (2020)
Modeling and mitigation of high-concentration antibody viscosity through structure-based computer-aided protein design
James R. Apgar et al.
PLOS ONE (2020)
An in vivo platform to select and evolve aggregation-resistant proteins
Jessica S. Ebo et al.
NATURE COMMUNICATIONS (2020)
Insight into the protein solubility driving forces with neural attention
Daniele Raimondi et al.
PLoS Computational Biology (2020)
Physicochemical Rules for Identifying Monoclonal Antibodies with Drug-like Specificity
Yulei Zhang et al.
MOLECULAR PHARMACEUTICS (2020)
A single molecular descriptor to predict solution behavior of therapeutic antibodies
Jonathan S. Kingsbury et al.
SCIENCE ADVANCES (2020)
In Pursuit of Stability Enhancement of a Prostate Cancer Targeting Antibody Derived from a Transgenic Animal Platform
Sathya Venkataramani et al.
SCIENTIFIC REPORTS (2020)
Pharmacokinetic prediction of an antibody in mice based on an in vitro cell-based approach using target receptor-expressing cells
Yuki Noguchi et al.
SCIENTIFIC REPORTS (2020)
Influence of physiochemical properties on the subcutaneous absorption and bioavailability of monoclonal antibodies
Amita Datta-Mannan et al.
MABS (2020)
Cross-Interaction Chromatography-Based QSAR Model for Early-Stage Screening to Facilitate Enhanced Developability of Monoclonal Antibody Therapeutics
Arathi Kizhedath et al.
BIOTECHNOLOGY JOURNAL (2019)
Five computational developability guidelines for therapeutic antibody profiling
Matthew I. J. Raybould et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Phage display derived therapeutic antibodies have enriched aliphatic content: Insights for developability issues
Nazli Eda Kaleli et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2019)
An in vitro FcRn- dependent transcytosis assay as a screening tool for predictive assessment of nonspecific clearance of antibody therapeutics in humans
Shan Chung et al.
MABS (2019)
Advances in liquid formulations of parenteral therapeutic proteins
Robert J. Falconer
BIOTECHNOLOGY ADVANCES (2019)
The Neonatal Fc Receptor (FcRn): A Misnomer?
Michal Pyzik et al.
FRONTIERS IN IMMUNOLOGY (2019)
TCPro: an In Silico Risk Assessment Tool for Biotherapeutic Protein Immunogenicity
Osman N. Yogurtcu et al.
AAPS JOURNAL (2019)
Application of interpretable artificial neural networks to early monoclonal antibodies development
Lorenzo Gentiluomo et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2019)
Optimizing antibody affinity and stability by the automated design of the variable light-heavy chain interfaces
Shira Warszawski et al.
PLOS COMPUTATIONAL BIOLOGY (2019)
Physiologically-based modeling of monoclonal antibody pharmacokinetics in drug discovery and development
Patrick M. Glassman et al.
DRUG METABOLISM AND PHARMACOKINETICS (2019)
High-Throughput Mapping of B Cell Receptor Sequences to Antigen Specificity
Ian Setliff et al.
CELL (2019)
Structure, heterogeneity and developability assessment of therapeutic antibodies
Yingda Xu et al.
MABS (2019)
In vitro and in silico assessment of the developability of a designed monoclonal antibody library
Adriana-Michelle Wolf Perez et al.
MABS (2019)
A Physiologically-Based Pharmacokinetic Model for the Prediction of Monoclonal Antibody Pharmacokinetics From In Vitro Data
Hannah M. Jones et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2019)
Impact of electroviscous effect on viscosity in developing highly concentrated protein formulations: Lessons from non-protein charged colloids
Jinjiang Li et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS-X (2019)
Massively parallel single-cell B-cell receptor sequencing enables rapid discovery of diverse antigen-reactive antibodies
Leonard D. Goldstein et al.
COMMUNICATIONS BIOLOGY (2019)
Understanding and overcoming trade-offs between antibody affinity, specificity, stability and solubility
Lilia A. Rabia et al.
BIOCHEMICAL ENGINEERING JOURNAL (2018)
DeepSol: a deep learning framework for sequence-based protein solubility prediction
Sameer Khurana et al.
BIOINFORMATICS (2018)
Tutorial on Monoclonal Antibody Pharmacokinetics and Its Considerations in Early Development
Meric Ovacik et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2018)
Immunogenicity of biologic therapies: causes and consequences
Wolf-Henning Boehncke et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2018)
Directed evolution of a picomolar-affinity, high-specificity antibody targeting phosphorylated tau
Dan Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Development of a label-free FcRn-mediated transcytosis assay for in vitro characterization of FcRn interactions with therapeutic antibodies and Fc-fusion proteins
Shan Chung et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2018)
Establishing in vitro in vivo correlations to screen monoclonal antibodies for physicochemical properties related to favorable human pharmacokinetics
Lindsay B. Avery et al.
MABS (2018)
Monoclonal antibody higher order structure analysis by high throughput protein conformational array
Yuanli Song et al.
MABS (2018)
Subcutaneous delivery of monoclonal antibodies: How do we get there?
Margarida Viola et al.
JOURNAL OF CONTROLLED RELEASE (2018)
MHC-associated peptide proteomics enabling highly sensitive detection of immunogenic sequences for the development of therapeutic antibodies with low immunogenicity
Nobuo Sekiguchi et al.
MABS (2018)
Net charge of antibody complementarity-determining regions is a key predictor of specificity
Lilia A. Rabia et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2018)
Humanization of Antibodies using a Statistical Inference Approach
Alejandro Clavero-Alvarez et al.
SCIENTIFIC REPORTS (2018)
Developability Assessment of Engineered Monoclonal Antibody Variants with a Complex Self-Association Behavior Using Complementary Analytical and in Silico Tools
Lu Shan et al.
MOLECULAR PHARMACEUTICS (2018)
PaRSnIP: sequence-based protein solubility prediction using gradient boosting machine
Reda Rawi et al.
BIOINFORMATICS (2018)
Monoclonal antibodies: technologies for early discovery and engineering
Patrick J. Kennedy et al.
CRITICAL REVIEWS IN BIOTECHNOLOGY (2018)
Arginine mutations in antibody complementarity-determining regions display context-dependent affinity/specificity trade-offs
Kathryn E. Tiller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Prediction and Reduction of the Aggregation of Monoclonal Antibodies
Rob van der Kant et al.
JOURNAL OF MOLECULAR BIOLOGY (2017)
Utility of High Throughput Screening Techniques to Predict Stability of Monoclonal Antibody Formulations During Early Stage Development
Deborah S. Goldberg et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
In-silico prediction of concentration-dependent viscosity curves for monoclonal antibody solutions
Dheeraj S. Tomar et al.
MABS (2017)
SODA: prediction of protein solubility from disorder and aggregation propensity
Lisanna Paladin et al.
NUCLEIC ACIDS RESEARCH (2017)
High Throughput Prediction Approach for Monoclonal Antibody Aggregation at High Concentration
Mitja Zidar et al.
PHARMACEUTICAL RESEARCH (2017)
Computationally optimized deimmunization libraries yield highly mutated enzymes with low immunogenicity and enhanced activity
Regina S. Salvat et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Biophysical properties of the clinical-stage antibody landscape
Tushar Jain et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Efficient affinity maturation of antibody variable domains requires co-selection of compensatory mutations to maintain thermodynamic stability
Mark C. Julian et al.
SCIENTIFIC REPORTS (2017)
Rapid and accurate in silico solubility screening of a monoclonal antibody library
Pietro Sormanni et al.
SCIENTIFIC REPORTS (2017)
Antigen-specific single B cell sorting and expression-cloning from immunoglobulin humanized rats: a rapid and versatile method for the generation of high affinity and discriminative human monoclonal antibodies
Laure-Helene Ouisse et al.
BMC BIOTECHNOLOGY (2017)
Computational tool for the early screening of monoclonal antibodies for their viscosities
Neeraj J. Agrawal et al.
MABS (2016)
Rational design of therapeutic mAbs against aggregation through protein engineering and incorporation of glycosylation motifs applied to bevacizumab
Fabienne Courtois et al.
MABS (2016)
PON-Sol: prediction of effects of amino acid substitutions on protein solubility
Yang Yang et al.
BIOINFORMATICS (2016)
Engineering antibody therapeutics
Mark L. Chiu et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2016)
Immunogenicity of Therapeutic Protein Aggregates
Ehab M. Moussa et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Secukinumab, a novel anti-IL-17A antibody, shows low immunogenicity potential in human in vitro assays comparable to other marketed biotherapeutics with low clinical immunogenicity
Anette Karle et al.
MABS (2016)
Mitigation of reversible self-association and viscosity in a human IgG1 monoclonal antibody by rational, structure-guided Fv engineering
James C. Geoghegan et al.
MABS (2016)
Charge-mediated Fab-Fc interactions in an IgG1 antibody induce reversible self-association, cluster formation, and elevated viscosity
Jayant Arora et al.
MABS (2016)
Molecular basis of high viscosity in concentrated antibody solutions: Strategies for high concentration drug product development
Dheeraj S. Tomar et al.
MABS (2016)
Measurements of Monoclonal Antibody Self-Association Are Correlated with Complex Biophysical Properties
Steven B. Geng et al.
MOLECULAR PHARMACEUTICS (2016)
Computationally driven antibody engineering enables simultaneous humanization and thermostabilization
Yoonjoo Choi et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2016)
Solubis: a webserver to reduce protein aggregation through mutation
Joost Van Durme et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2016)
The diversity of H3 loops determines the antigen-binding tendencies of antibody CDR loops
Yuko Tsuchiya et al.
PROTEIN SCIENCE (2016)
Use of In Vitro Assays to Assess Immunogenicity Risk of Antibody-Based Biotherapeutics
Marisa K. Joubert et al.
PLOS ONE (2016)
Engineering the surface properties of a human monoclonal antibody prevents self-association and rapid clearance in vivo
Claire L. Dobson et al.
SCIENTIFIC REPORTS (2016)
Engineered Autonomous Human Variable Domains
Johan Nilvebrant et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
High-Throughput Assay for Measuring Monoclonal Antibody Self-Association and Aggregation in Serum
Xiaoning Li et al.
BIOCONJUGATE CHEMISTRY (2015)
Solubis: optimize your protein
Greet De Baets et al.
BIOINFORMATICS (2015)
Protein deimmunization via structure-based design enables efficient epitope deletion at high mutational loads
Regina S. Salvat et al.
BIOTECHNOLOGY AND BIOENGINEERING (2015)
Evaluating the Use of Antibody Variable Region (Fv) Charge as a Risk Assessment Tool for Predicting Typical Cynomolgus Monkey Pharmacokinetics
Daniela Bumbaca Yadav et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
FcRn: The Architect Behind the Immune and Nonimmune Functions of IgG and Albumin
Michal Pyzik et al.
JOURNAL OF IMMUNOLOGY (2015)
The CamSol Method of Rational Design of Protein Mutants with Enhanced Solubility
Pietro Sormanni et al.
JOURNAL OF MOLECULAR BIOLOGY (2015)
Mechanism of Reversible Self-Association of a Monoclonal Antibody: Role of Electrostatic and Hydrophobic Interactions
Reza Esfandiary et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Developability Assessment During the Selection of Novel Therapeutic Antibodies
Alexander Jarasch et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
High throughput cross-interaction measures for human IgG1 antibodies correlate with clearance rates in mice
Ryan L. Kelly et al.
MABS (2015)
The interplay of non-specific binding, target-mediated clearance and FcRn interactions on the pharmacokinetics of humanized antibodies
Amita Datta-Mannan et al.
MABS (2015)
Aggregation risk prediction for antibodies and its application to biotherapeutic development
Olga Obrezanova et al.
MABS (2015)
Balancing charge in the complementarity-determining regions of humanized mAbs without affecting pI reduces non-specific binding and improves the pharmacokinetics
Amita Datta-Mannan et al.
MABS (2015)
Hydrogen exchange mass spectrometry reveals protein interfaces and distant dynamic coupling effects during the reversible self-association of an IgG1 monoclonal antibody
Jayant Arora et al.
MABS (2015)
Antibody humanization by structure-based computational protein design
Yoonjoo Choi et al.
MABS (2015)
Rational design of viscosity reducing mutants of a monoclonal antibody: Hydrophobic versus electrostatic inter-molecular interactions
Pilarin Nichols et al.
MABS (2015)
Charge-mediated influence of the antibody variable domain on FcRn-dependent pharmacokinetics
Angela Schoch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Discovery of highly soluble antibodies prior to purification using affinity-capture self-interaction nanoparticle spectroscopy
Jiemin Wu et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2015)
Directed evolution of anti-HER2 DARPins by SNAP display reveals stability/function trade-offs in the selection process
Gillian Houlihan et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2015)
Computationally driven deletion of broadly distributed T cell epitopes in a biotherapeutic candidate
Regina S. Salvat et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Immunogenicity of therapeutic proteins: Influence of aggregation
Kirsty D. Ratanji et al.
JOURNAL OF IMMUNOTOXICOLOGY (2014)
Entanglement Model of Antibody Viscosity
Jeremy D. Schmit et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2014)
High-throughput screening for developability during early-stage antibody discovery using self-interaction nanoparticle spectroscopy
Yuqi Liu et al.
MABS (2014)
Framework selection can influence pharmacokinetics of a humanized therapeutic antibody through differences in molecule charge
Bing Li et al.
MABS (2014)
In silico selection of therapeutic antibodies for development: Viscosity, clearance, and chemical stability
Vikas K. Sharma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Pharmacokinetics, Pharmacodynamics and Physiologically-Based Pharmacokinetic Modelling of Monoclonal Antibodies
Miroslav Dostalek et al.
CLINICAL PHARMACOKINETICS (2013)
Rapid Analysis of Antibody Self-Association in Complex Mixtures Using Immunogold Conjugates
Shantanu V. Sule et al.
MOLECULAR PHARMACEUTICS (2013)
Addressing polyspecificity of antibodies selected from an in vitro yeast presentation system: a FACS-based, high-throughput selection and analytical tool
Yingda Xu et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2013)
Immunogenicity to Biologics: Mechanisms, Prediction and Reduction
Swaminathan Sethu et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2012)
Weak Interactions Govern the Viscosity of Concentrated Antibody Solutions: High-Throughput Analysis Using the Diffusion Interaction Parameter
Brian D. Connolly et al.
BIOPHYSICAL JOURNAL (2012)
Monoclonal antibody therapeutics: history and future
Nicholas A. P. S. Buss et al.
CURRENT OPINION IN PHARMACOLOGY (2012)
PROSO II - a new method for protein solubility prediction
Pawel Smialowski et al.
FEBS JOURNAL (2012)
Developability index: A rapid in silico tool for the screening of antibody aggregation propensity
Timothy M. Lauer et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Viscosity behavior of high-concentration monoclonal antibody solutions: Correlation with interaction parameter and electroviscous effects
Sandeep Yadav et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Solution pH That Minimizes Self-Association of Three Monoclonal Antibodies Is Strongly Dependent on Ionic Strength
Shantanu V. Sule et al.
MOLECULAR PHARMACEUTICS (2012)
The Influence of Charge Distribution on Self-Association and Viscosity Behavior of Monoclonal Antibody Solutions
Sandeep Yadav et al.
MOLECULAR PHARMACEUTICS (2012)
Minipig as a potential translatable model for monoclonal antibody pharmacokinetics after intravenous and subcutaneous administration
Yanan Zheng et al.
MABS (2012)
A strategy for risk mitigation of antibodies with fast clearance
Isidro Hoetzel et al.
MABS (2012)
Solubility evaluation of murine hybridoma antibodies
Stacey Spencer et al.
MABS (2012)
Aggregation-resistant domain antibodies engineered with charged mutations near the edges of the complementarity-determining regions
Joseph M. Perchiacca et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2012)
Engineering Aggregation-Resistant Antibodies
Joseph M. Perchiacca et al.
ANNUAL REVIEW OF CHEMICAL AND BIOMOLECULAR ENGINEERING, VOL 3 (2012)
Aggregates in Monoclonal Antibody Manufacturing Processes
Maria Vazquez-Rey et al.
BIOTECHNOLOGY AND BIOENGINEERING (2011)
Assessment of Net Charge and Protein-Protein Interactions of Different Monoclonal Antibodies
Christian Lehermayr et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Beyond natural antibodies: the power of in vitro display technologies
Andrew R. M. Bradbury et al.
NATURE BIOTECHNOLOGY (2011)
Establishing a Link Between Amino Acid Sequences and Self-Associating and Viscoelastic Behavior of Two Closely Related Monoclonal Antibodies
Sandeep Yadav et al.
PHARMACEUTICAL RESEARCH (2011)
Viscosity Analysis of High Concentration Bovine Serum Albumin Aqueous Solutions
Sandeep Yadav et al.
PHARMACEUTICAL RESEARCH (2011)
Mutational analysis of domain antibodies reveals aggregation hotspots within and near the complementarity determining regions
Joseph M. Perchiacca et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2011)
Diffusion and Sedimentation Interaction Parameters for Measuring the Second Virial Coefficient and Their Utility as Predictors of Protein Aggregation
Atul Saluja et al.
BIOPHYSICAL JOURNAL (2010)
Factors Affecting the Viscosity in High Concentration Solutions of Different Monoclonal Antibodies
Sandeep Yadav et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Specific Interactions in High Concentration Antibody Solutions Resulting in High Viscosity
Sandeep Yadav et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Charge variants in IgG1 Isolation, characterization, in vitro binding properties and pharmacokinetics in rats
Leslie A. Khawli et al.
MABS (2010)
Cross-Interaction Chromatography: A Rapid Method to Identify Highly Soluble Monoclonal Antibody Candidates
Steven A. Jacobs et al.
PHARMACEUTICAL RESEARCH (2010)
Stability engineering of scFvs for the development of bispecific and multivalent antibodies
Brian R. Miller et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2010)
Structure-based engineering of a monoclonal antibody for improved solubility
Sheng-Jiun Wu et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2010)
Reduced elimination of IgG antibodies by engineering the variable region
T. Igawa et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2010)
Formulation and manufacturability of biologics
Steven J. Shire
CURRENT OPINION IN BIOTECHNOLOGY (2009)
Design of therapeutic proteins with enhanced stability
Naresh Chennamsetty et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Reversible self-association of a concentrated monoclonal antibody solution mediated by Fab-Fab interaction that impacts solution viscosity
Sonoko Kanai et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Immunogenicity of protein therapeutics
Anne S. De Groot et al.
TRENDS IN IMMUNOLOGY (2007)
Computational design of antibody-affinity improvement beyond in vivo maturation
Shaun M. Lippow et al.
NATURE BIOTECHNOLOGY (2007)
Antibody structure, instability, and formulation
Wei Wang et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
FcRn: the neonatal Fc receptor comes of age
Derry C. Roopenian et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Effects of protein aggregates: An immunologic perspective
Amy S. Rosenberg
AAPS JOURNAL (2006)
Reversible self-association increases the viscosity of a concentrated monoclonal antibody in aqueous solution
J Liu et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
Protein drug stability: A formulation challenge
S Frokjaer et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Human antibodies from transgenic animals
N Lonberg
NATURE BIOTECHNOLOGY (2005)
Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins
AM Fernandez-Escamilla et al.
NATURE BIOTECHNOLOGY (2004)
Antibody pharmacokinetics and pharmacodynamics
ED Lobo et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Chromatographic measurement of interactions between unlike proteins
CA Teske et al.
FLUID PHASE EQUILIBRIA (2004)
Direct measurement of protein osmotic second virial cross coefficients by cross-interaction chromatography
PM Tessier et al.
PROTEIN SCIENCE (2004)
Therapeutic antibodies for human diseases at the dawn of the twenty-first century
OH Brekke et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
ProPred: prediction of HLA-DR binding sites
H Singh et al.
BIOINFORMATICS (2001)
The SH3-fold family: Experimental evidence and prediction of variations in the folding pathways
R Guerois et al.
JOURNAL OF MOLECULAR BIOLOGY (2000)
Antibody humanization: a case of the 'Emperor's new clothes'?
M Clark
IMMUNOLOGY TODAY (2000)
分享论文
